Bernard Fuemmeler, F., Ph.D., M.P.H.
Associate director for cancer prevention and control, VCU Massey Cancer Center
Gordon D. Ginder, M.D., Chair in Cancer Research
Research program member: Cancer Prevention and Control
830 E. Main St.
Richmond, VA 23298
Professor, Health Behavior and Policy, School of Medicine
MS, Oklahoma State University (1998)
PhD, Oklahoma State University (2001)
MPH, Harvard University (2003)
As associate director of cancer prevention and control, Dr. Fuemmeler is responsible for the development and coordination of Massey's cancer prevention and control research program, a matrix center with faculty from several schools and departments across the campus. He also works closely with Massey senior leaders to further enhance innovative transdisciplinary research. He also serves on Massey's executive leadership committee, which is charged with setting and assessing the center's strategic plans, policies, and priorities. His research in cancer prevention takes a life-course approach toward understanding the biological and social factors contributing the onset of cancer-related health behaviors, such as childhood obesity adolescent tobacco use. Applying digital and mobile health approaches, he has led the development of several apps and informatics platforms that have been used in observational and implementation research with cancer patients and population cohorts. He has authored more than 70 publications and holds one U.S. patent for his work in mHealth. Dr. Fuemmeler serves as a co-program director for Massey Cancer Center's T32 training program in cancer prevention and control funded by the National Cancer Institute. He is also on the editorial board of the Journal of Pediatric Psychology and is an associate editor for Annals of Behavioral Medicine. His work has been continuously supported for the past 20 years by extramural grants and awards from the NIH and several foundations.
Environmental tobacco smoke exposure, adolescent smoking, childhood obesity epidemiology, AYA cancer survivor health, HPV vaccination uptake